Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status

Nature Communications

Volumn 5, Issue , 2014, Pages

  Everard, Amandine ^a   Geurts, Lucie ^a   Caesar, Robert ^b   Van Hul, Matthias ^a   Matamoros, Sébastien ^a   Duparc, Thibaut ^a   Denis, Raphael G P ^c   Cochez, Perrine ^a   Pierard, Florian ^a   Castel, Julien ^c   Bindels, Laure B ^a   Plovier, Hubert ^a   Robine, Sylvie ^d   Muccioli, Giulio G ^a   Renauld, Jean Christophe ^a   Dumoutier, Laure ^a   Delzenne, Nathalie M ^a   Luquet, Serge ^c   Bäckhed, Fredrik ^b   Cani, Patrice D ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOCANNABINOID; MYELOID DIFFERENTIATION FACTOR 88; POLYPEPTIDE ANTIBIOTIC AGENT; GLUCOSE; MYD88 PROTEIN, MOUSE;

ENERGY USE; GERM CELL; IMMUNE SYSTEM; METABOLISM; NUTRITIONAL STATUS; OBESITY; PEPTIDE; SENSOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOSENSOR; CONTROLLED STUDY; DIET INDUCED OBESITY; ENERGY EXPENDITURE; FAT MASS; FATTY LIVER; GLUCOSE HOMEOSTASIS; INFLAMMATION; INTESTINE EPITHELIUM; INTESTINE FLORA; MOUSE; NONHUMAN; NUTRITIONAL STATUS; RECIPIENT; REGULATORY T LYMPHOCYTE; ANIMAL; C57BL MOUSE; CYTOLOGY; ENERGY METABOLISM; EPITHELIUM CELL; FEMALE; GENE DELETION; GENETICS; HUMAN; INTESTINE; KNOCKOUT MOUSE; MALE; METABOLISM; OBESITY;

ANIMALS; ENERGY METABOLISM; EPITHELIAL CELLS; FEMALE; GENE DELETION; GLUCOSE; HUMANS; INTESTINES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; NUTRITIONAL STATUS; OBESITY;

EID: 84923261268     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms6648     Document Type: Article

References (57)

1. Larsen, N. et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS ONE 5, e9085 (2010).
2. Wu, X. et al. Molecular characterisation of the faecal microbiota in patients with type II diabetes. Curr. Microbiol. 61, 69-78 (2010).
3. Qin, J. et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490, 55-60 (2012).
4. Karlsson, F. H. et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498, 99-103 (2013).
5. Turnbaugh, P. J. et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027-1031 (2006).
6. Cani, P. D. et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 1761-1772 (2007).
7. Cani, P. D. et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57, 1470-1481 (2008).
8. Adolph, T. E. et al. Paneth cells as a site of origin for intestinal inflammation. Nature 503, 272-276 (2013).
9. Rosenstiel, P. Stories of love and hate: innate immunity and host-microbe crosstalk in the intestine. Curr. Opin. Gastroenterol. 29, 125-132 (2013).
10. Vijay-Kumar, M. et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328, 228-231 (2010).
11. Kim, K. A., Gu, W., Lee, I. A., Joh, E. H. & Kim, D. H. High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS ONE 7, e47713 (2012).
12. Wen, L. et al. Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature 455, 1109-1113 (2008).
13. Hosoi, T., Yokoyama, S., Matsuo, S., Akira, S. & Ozawa, K. Myeloid differentiation factor 88 (MyD88)-deficiency increases risk of diabetes in mice. PLoS One 5, e12537 (2010).
14. Kleinridders, A. et al. MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity. Cell. Metab. 10, 249-259 (2009).
15. Yokoyama, S., Hosoi, T. & Ozawa, K. Stearoyl-CoA Desaturase 1 (SCD1) is a key factor mediating diabetes in MyD88-deficient mice. Gene 497, 340-343 (2012).
16. Osborn, O. & Olefsky, J. M. The cellular and signaling networks linking the immune system and metabolism in disease. Nat. Med. 18, 363-374 (2012).
17. Schwartz, D. R. & Lazar, M. A. Human resistin: found in translation from mouse to man. Trends Endocrinol. Metab. 22, 259-265 (2011).
18. Backhed, F. et al. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl Acad. Sci. USA 101, 15718-15723 (2004).
19. Mandard, S. et al. The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. J. Biol. Chem. 281, 934-944 (2006).
20. Neyrinck, A. M. et al. Dietary supplementation with chitosan derived from mushrooms changes adipocytokine profile in diet-induced obese mice, a phenomenon linked to its lipid-lowering action. Int. Immunopharmacol. 9, 767-773 (2009).
21. Soronen, J. et al. Adipose tissue gene expression analysis reveals changes in inflammatory, mitochondrial respiratory and lipid metabolic pathways in obese insulin-resistant subjects. BMC Med. Genomics 5, 9 (2012).
22. Everard, A. et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl Acad. Sci. USA 110, 9066-9071 (2013).
23. Muccioli, G. G. et al. The endocannabinoid system links gut microbiota to adipogenesis. Mol. Syst. Biol. 6, 392 (2010).
24. Geurts, L. et al. Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue. Front. Microbiol. 2, 149 (2011).
25. Kanarek, N. et al. Critical role for IL-1beta in DNA damage-induced mucositis. Proc. Natl Acad. Sci. USA 111, E702-E711 (2014).
26. Al-Sadi, R. et al. Mechanism of interleukin-1beta induced-increase in mouse intestinal permeability in vivo. J. Interferon Cytokine Res. 32, 474-484 (2012).
27. Al-Sadi, R., Ye, D., Said, H. M. & Ma, T. Y. IL-1beta-induced increase in intestinal epithelial tight junction permeability is mediated by MEKK-1 activation of canonical NF-kappaB pathway. Am. J. Pathol. 177, 2310-2322 (2010).
28. Dupaul-Chicoine, J. et al. Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. Immunity 32, 367-378 (2010).
29. Zaki, M. H. et al. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 32, 379-391 (2010).
30. Vaishnava, S. et al. The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine. Science 334, 255-258 (2011).
31. Frantz, A. L. et al. Targeted deletion of MyD88 in intestinal epithelial cells results in compromised antibacterial immunity associated with downregulation of polymeric immunoglobulin receptor, mucin-2, and antibacterial peptides. Mucosal Immunol. 5, 501-512 (2012).
32. Everard, A. et al. Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity. ISME J. 8, 2116-2130 (2014).
33. Nutsch, K. M. & Hsieh, C. S. T cell tolerance and immunity to commensal bacteria. Curr. Opin. Immunol. 24, 385-391 (2012).
34. Round, J. L. & Mazmanian, S. K. Inducible Foxp3 + regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc. Natl Acad. Sci. USA 107, 12204-12209 (2010).
35. Fontenot, J. D. & Rudensky, A. Y. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat. Immunol. 6, 331-337 (2005).
36. Feuerer, M. et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat. Med. 15, 930-939 (2009).
37. Sheridan, B. S. et al. gammadelta T cells exhibit multifunctional and protective memory in intestinal tissues. Immunity 39, 184-195 (2013).
38. Spits, H. et al. Innate lymphoid cells-a proposal for uniform nomenclature. Nat. Rev. Immunol. 13, 145-149 (2013).
39. Turnbaugh, P. J., Backhed, F., Fulton, L. & Gordon, J. I. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3, 213-223 (2008).
40. Zhang, X. et al. Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. PLoS One 7, e42529 (2012).
41. Backhed, F., Manchester, J. K., Semenkovich, C. F. & Gordon, J. I. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc. Natl Acad. Sci. USA 104, 979-984 (2007).
42. Fleissner, C. K. et al. Absence of intestinal microbiota does not protect mice from diet-induced obesity. Br. J. Nutr. 104, 919-929 (2010).
43. Mizutani, N. et al. Reduction of insulin signaling upregulates angiopoietin-like protein 4 through elevated free fatty acids in diabetic mice. Exp. Clin. Endocrinol. Diabetes 120, 139-144 (2012).
44. Brown, R., Imran, S. A. & Wilkinson, M. Lipopolysaccharide (LPS) stimulates adipokine and socs3 gene expression in mouse brain and pituitary gland in vivo, and in N-1 hypothalamic neurons in vitro. J. Neuroimmunol. 209, 96-103 (2009).
45. Lu, B., Moser, A., Shigenaga, J. K., Grunfeld, C. & Feingold, K. R. The acute phase response stimulates the expression of angiopoietin like protein 4. Biochem. Biophys. Res. Commun. 391, 1737-1741 (2010).
46. Alhouayek, M., Lambert, D. M., Delzenne, N. M., Cani, P. D. & Muccioli, G. G. Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation. FASEB J. 25, 2711-2721 (2011).
47. Hansen, K. B. et al. 2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humans. J. Clin. Endocrinol. Metab. 96, E1409-E1417 (2011).
48. Cani, P. D. et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58, 1091-1103 (2009).
49. Bevins, C. L. & Salzman, N. H. Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis. Nat. Rev. Microbiol. 9, 356-368 (2011).
50. Pott, J. & Hornef, M. Innate immune signalling at the intestinal epithelium in homeostasis and disease. EMBO Rep. 13, 684-698 (2012).
51. Hooper, L. V. &Macpherson, A. J. Immune adaptations thatmaintain homeostasis with the intestinal microbiota. Nat. Rev. Immunol. 10, 159-169 (2010).
52. el Marjou, F. et al. Tissue-specific and inducible Cre-mediated recombination in the gut epithelium. Genesis 39, 186-193 (2004).
53. Joly-Amado, A. et al. Hypothalamic AgRP-neurons control peripheral substrate utilization and nutrient partitioning. EMBO J. 31, 4276-4288 (2012).
54. Dewulf, E. M. et al. Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut 62, 1112-1121 (2013).
55. Wu, G. D. et al. Sampling and pyrosequencing methods for characterizing bacterial communities in the human gut using 16S sequence tags. BMC Microbiol. 10, 206 (2010).
56. Caporaso, J. G. et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7, 335-336 (2010).
57. Letunic, I. & Bork, P. Interactive Tree Of Life v2: online annotation and display of phylogenetic trees made easy. Nucleic Acids Res. 39, W475-W478 (2011).